247 related articles for article (PubMed ID: 33831141)
1. Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease.
Agudelo M; Palus M; Keeffe JR; Bianchini F; Svoboda P; Salát J; Peace A; Gazumyan A; Cipolla M; Kapoor T; Guidetti F; Yao KH; Elsterová J; Teislerová D; Chrdle A; Hönig V; Oliveira T; West AP; Lee YE; Rice CM; MacDonald MR; Bjorkman PJ; Růžek D; Robbiani DF; Nussenzweig MC
J Exp Med; 2021 May; 218(5):. PubMed ID: 33831141
[TBL] [Abstract][Full Text] [Related]
2. Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses.
VanBlargan LA; Errico JM; Kafai NM; Burgomaster KE; Jethva PN; Broeckel RM; Meade-White K; Nelson CA; Himansu S; Wang D; Handley SA; Gross ML; Best SM; Pierson TC; Fremont DH; Diamond MS
J Exp Med; 2021 May; 218(5):. PubMed ID: 33831142
[TBL] [Abstract][Full Text] [Related]
3. Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.
Yang X; Qi J; Peng R; Dai L; Gould EA; Gao GF; Tien P
J Virol; 2019 Apr; 93(8):. PubMed ID: 30760569
[TBL] [Abstract][Full Text] [Related]
4. Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virus.
Matveev AL; Kozlova IV; Stronin OV; Khlusevich YA; Doroshchenko EK; Baykov IK; Lisak OV; Emelyanova LA; Suntsova OV; Matveeva VA; Savinova JS; Tikunova NV
PLoS One; 2019; 14(4):e0215075. PubMed ID: 30958863
[TBL] [Abstract][Full Text] [Related]
5. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
Chidumayo NN; Yoshii K; Kariwa H
Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
[TBL] [Abstract][Full Text] [Related]
7. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
8. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.
Orlinger KK; Hofmeister Y; Fritz R; Holzer GW; Falkner FG; Unger B; Loew-Baselli A; Poellabauer EM; Ehrlich HJ; Barrett PN; Kreil TR
J Infect Dis; 2011 Jun; 203(11):1556-64. PubMed ID: 21592984
[TBL] [Abstract][Full Text] [Related]
9. No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study.
Kohler P; Jonsdottir HR; Risch L; Vernazza P; Ackermann-Gäumann R; Kahlert CR
Sci Rep; 2021 Dec; 11(1):24198. PubMed ID: 34921220
[TBL] [Abstract][Full Text] [Related]
10. Characterization of neutralizing monoclonal antibody against tick-borne encephalitis virus in vivo.
Matveev A; Matveev L; Stronin O; Baykov I; Emeljanova L; Khlusevich Y; Tikunova N
Vaccine; 2020 Jun; 38(27):4309-4315. PubMed ID: 32409136
[TBL] [Abstract][Full Text] [Related]
11. Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination.
Jarmer J; Zlatkovic J; Tsouchnikas G; Vratskikh O; Strauß J; Aberle JH; Chmelik V; Kundi M; Stiasny K; Heinz FX
J Virol; 2014 Dec; 88(23):13845-57. PubMed ID: 25253341
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
[TBL] [Abstract][Full Text] [Related]
13. A single chain antibody fragment expressed in bacteria neutralizes tick-borne flaviviruses.
Jiang W; Bonnert TP; Venugopal K; Gould EA
Virology; 1994 Apr; 200(1):21-8. PubMed ID: 8128623
[TBL] [Abstract][Full Text] [Related]
14. Chimeric antibodies against tick-borne encephalitis virus.
Levanov LN; Matveev LE; Goncharova EP; Lebedev LR; Ryzhikov AB; Yun TE; Batanova TA; Shvalov AN; Baykov IK; Shingarova LN; Kirpichnikov MP; Tikunova NV
Vaccine; 2010 Jul; 28(32):5265-71. PubMed ID: 20538092
[TBL] [Abstract][Full Text] [Related]
15. A combination of two resistance mechanisms is critical for tick-borne encephalitis virus escape from a broadly neutralizing human antibody.
Svoboda P; Haviernik J; Bednar P; Matkovic M; Cervantes Rincón T; Keeffe J; Palus M; Salat J; Agudelo M; Nussenzweig MC; Cavalli A; Robbiani DF; Ruzek D
Cell Rep; 2023 Sep; 42(9):113149. PubMed ID: 37715951
[TBL] [Abstract][Full Text] [Related]
16. Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.
Tsouchnikas G; Zlatkovic J; Jarmer J; Strauß J; Vratskikh O; Kundi M; Stiasny K; Heinz FX
J Virol; 2015 Aug; 89(15):7970-8. PubMed ID: 26018152
[TBL] [Abstract][Full Text] [Related]
17. Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy.
Pripuzova NS; Gmyl LV; Romanova LIu; Tereshkina NV; Rogova YV; Terekhina LL; Kozlovskaya LI; Vorovitch MF; Grishina KG; Timofeev AV; Karganova GG
PLoS One; 2013; 8(4):e61094. PubMed ID: 23585873
[TBL] [Abstract][Full Text] [Related]
18. The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection.
Lindqvist R; Rosendal E; Weber E; Asghar N; Schreier S; Lenman A; Johansson M; Dobler G; Bestehorn M; Kröger A; Överby AK
J Neuroinflammation; 2020 Sep; 17(1):284. PubMed ID: 32988388
[TBL] [Abstract][Full Text] [Related]
19. Geographic distribution of Tick-borne encephalitis virus complex.
Im JH; Baek JH; Durey A; Kwon HY; Chung MH; Lee JS
J Vector Borne Dis; 2020; 57(1):14-22. PubMed ID: 33818450
[TBL] [Abstract][Full Text] [Related]
20. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
